Notable Wednesday Option Activity: GS, LLY, RDDT

Eli Lilly (LLY) saw 33,369 options contracts trade today (≈3.3M underlying shares), equal to roughly 124.4% of its one‑month ADTV (2.7M shares), with concentrated activity in the $1,100 call expiring Jan 23, 2026 (3,487 contracts ≈348,700 shares). Reddit (RDDT) logged 48,352 contracts (≈4.8M shares), about 121.6% of its one‑month ADTV (4.0M shares), led by the $245 call expiring Jan 23, 2026 (4,261 contracts ≈426,100 shares). The size and concentration of these long‑dated call flows point to notable options positioning that could drive hedging-related share flows in the underlying names.

Analysis

Market structure: The outsized options flow (LLY ~3.3m shares notional, RDDT ~4.8m) concentrated in single, long‑dated call strikes implies directional bullish positioning or hedged speculative blocks. Market‑maker dealers who sold these calls will delta‑hedge by buying underlying, creating near‑term positive price pressure until positions are neutralized; expect amplified moves in the next 1–10 trading days and elevated term IV for 2026 expiries (skew steepening). This benefits large liquidity providers and long‑gamma players, and pressures short‑gamma retail/hedge strategies.

Risk assessment: Tail scenarios include M&A or surprise fundamental news (positive catalyst) that would massively revalue these long calls, or regulatory/earnings shocks that render deep OTM calls worthless; both are low‑probability but high‑impact. Immediate (days) risk is flow‑driven volatility; short term (weeks–months) risk is IV mean reversion; long term (quarters) fundamentals and monetization (RDDT) or pipeline/regulatory outcomes (LLY) dominate. Hidden dependency: large block sellers may be hedging other correlated positions (indices, ETFs), so flow could reverse if hedges unwind.

Trade implications: For tactical alpha, exploit dealer hedging and IV dislocations: (a) small directional exposure to LLY/RDDT to ride delta‑hedge flows over 1–10 days; (b) sell short‑dated OTM premium if IV rank >75th percentile to harvest inflated premia; (c) use capped‑loss call‑debit spreads to capture upside while limiting tail risk. Position sizing should be modest (0.25–2% NAV) and scaled into realized volatility and news flow.

Contrarian angles: The market may misread heavy call volume as durable conviction; often these are one‑off block trades, convertible arb hedges, or corporate hedges that don’t imply fundamental change. Reaction could be overdone: price pops from dealer hedging can retrace when positions are squared, leaving option buyers with time decay; historical parallels include biotech call bursts that reversed absent news. Unintended consequence: aggressive short premium strategies can be gamma‑punished if a true catalyst emerges — size accordingly.

Key Decisions for Investors

• Establish a tactical 1% long position in LLY equity or buy a capped call‑debit spread referencing the Jan 23, 2026 $1100 strike (buy lower strike / sell $1100) sized at 0.5–1% NAV to capture dealer delta‑hedge upside over the next 1–10 days; trim 50% if LLY rallies >5% in 3 trading days or IV falls >20% from peak.
• For RDDT, allocate 0.5–1% NAV to a long call‑spread anchored at the active $245 Jan‑2026 call (buy $245 / sell ~$325) to limit downside while participating in a speculative upside; cap exposure if notional open interest in that strike rises above 10k contracts or headlines on monetization/regulation appear.
• If IV for either ticker’s 30–60 day options ranks above its 75th percentile, sell small-size (0.25–0.5% NAV) OTM short strangles (delta ~0.20) with strict 3‑day 3–5% stop levels or option buybacks at 2x P/L to harvest elevated premium from dealer hedging flows.
• Implement a relative‑value pair: long LLY equal‑notional vs short XLV or a large-cap pharma peer (e.g., MRK) for 1% net exposure to isolate idiosyncratic upside; close if basis widens >7% or sector news changes fundamentals within 30 days.